BENJAMIN CARLYLE: Open Payments
NPI 1184882383 · FARMINGTON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 19 payments from 8 companies in 2025. Trend: 2023 $523 · 2024 $810 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $230 |
| Gilead Sciences, Inc. | 3 | $65 |
| Lilly USA, LLC | 3 | $46 |
| Braeburn Inc. | 2 | $39 |
| PFIZER INC. | 1 | $22 |
| Indivior Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
Products named: Ozempic, MOUNJARO, Rybelsus, BRIXADI, NURTEC ODT, SUBLOCADE, Kerendia, VIVITROL.
Industry payments across AR — which companies pay providers there.
